Singapore General Hospital

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Pipeline

Pipeline Snapshot

By Phase

2 drugs in development

Approved1

Phase 21

Preclinical1

By Therapeutic Area

top 6

Dermatology

225%

Immunology

113%

Infectious Disease

113%

Neurology

113%

Hematology

113%

Oncology

113%

R&D Momentum

56/100

Pipeline Velocity

27/100

Trial Completion Rate

78/100

Pipeline Concentration

16/100

Pipeline Freshness

54/100

Strategic Signals

↗Active in Immunology but thin pipeline — potential licensing opportunity

Activity

Recent Activity

Last 14 days

Oct 28, 2026

Recruiting

Investigating the Effects of Dietary Glycine Supplementation in Patients With Metabolic Dysfunction-associated Steatotic Liver Disease

Oct 28, 2026

Completed

Investigating the Prevalence and Risk Factors for Sarcopenia Amongst Adults Seeking Treatment for Obesity

Oct 27, 2026

Recruiting

Cost and Outcomes of Hospital-based Physiotherapy Versus mHealth-based Self-directed Rehabilitation in Patients With Knee Osteoarthritis: A Randomized, Controlled, Non-inferiority Trial

Earlier

Sep 30, 2026TrialMedication Facilitated Ureteral Access Sheath Deployment During Ureteroscopy: The Impact of One Week of Preoperative Tamsulosin

Aug 28, 2026TrialSerious Illness Coaching for Patients With Advanced Cancer Undergoing Palliative Interventions

Aug 21, 2026TrialAssessment of Treatment Response in Immune-mediated Myositis Associated Rapidly-progressing Interstitial Lung Disease

Aug 20, 2026TrialFormative Evaluation of a Mobile Application Facilitated Self-Directed Rehabilitation Programme for the Conservative Management of Knee Osteoarthritis

Aug 19, 2026TrialAssessment of Revascularization in Plantar Foot of Diabetic Mellitus Patients Pre and Post Angioplasty Using Spatial Frequency Domain Imaging

4 more events

Aug 18, 2026TrialComplementary Herbal Approach to Rheumatoid Management Study (CHARMS)

Jul 29, 2026TrialThe Effectiveness and Acceptability of Inhalation Aromatherapy for Patients Undergoing Conservative Sharp Wound Debridement: A Pilot Randomized Controlled Trial

Jul 14, 2026TrialDurian Consumption on Human Microbiome and Metabolome in Adults With Type 2 Diabetes Mellitus (DURIOME-T2D)

Jan 1, 2026TrialIntegrating Allogeneic NK Cells in High-risk Advanced Stage III-IV Nasopharyngeal Cancer Patients

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Pipeline

Drug Pipeline

Indication

Preclinical

Phase 1

Phase 2

Phase 3

Approved

SoriatanePreclinical

Hematology

Amyloidosis

SoriataneApproved

Immunology

Psoriasis

SoriataneApproved

Infectious Disease

HIV Infection

SoriataneApproved

Neurology

Alzheimer Disease

SoriataneApproved

Oncology

Skin Cancer

SoriatanePreclinical

Unknown / Other

Skin Rash

SoriataneApproved

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)